R. Takimoto-Ito

发表

Advances in the pathophysiology of atopic dermatitis revealed by novel therapeutics and clinical trials.

Xiaoliang Yang, K. Kabashima, N. Kambe, 2021, Pharmacology & therapeutics.

Potential Benefits of TNF Targeting Therapy in Blau Syndrome, a NOD2-Associated Systemic Autoinflammatory Granulomatosis

N. Kambe, S. Takei, N. Kanazawa, 2022, Frontiers in Immunology.

The Potential Role of Basophils in Urticaria

K. Kabashima, N. Kambe, Izumi Kishimoto, 2022, Frontiers in Immunology.

Decreased peripheral basophil counts in urticaria and mouse model of oxazolone-induced hypersensitivity, the latter suggesting basopenia reflecting migration to skin

A. Otsuka, N. Kambe, A. Walls, 2022, Frontiers in Immunology.

Hereditary angioedema with a novel mutation, c.1481G>C, in the SERPING1 gene

K. Kabashima, N. Kambe, K. Izawa, 2021, Journal of Cutaneous Immunology and Allergy.

A New Era with the Development of Cytokine-Based Therapy for Pruritus.

K. Kabashima, N. Kambe, R. Takimoto-Ito, 2021, The Journal of investigative dermatology.

Similarities and differences in autoinflammatory diseases with urticarial rash, cryopyrin-associated periodic syndrome and Schnitzler syndrome.

D. Lipsker, N. Kambe, T. Matsuda, 2023, Allergology international : official journal of the Japanese Society of Allergology.

Skin‐associated lymphoid tissue could be a sign of systemic disease: reply from authors

T. Nomura, K. Kabashima, N. Kambe, 2021, The British journal of dermatology.

Tofacitinib, a suppressor of NOD2 expression, is a potential treatment for Blau syndrome

N. Kambe, M. Saito, H. Tanizaki, 2023, Frontiers in Immunology.

Refractory serum immunoglobulin M elevation during anti‐interleukin (IL)‐1‐ or IL‐6‐targeted treatment in four patients with Schnitzler syndrome

T. Nomura, K. Kabashima, A. Otsuka, 2021, The Journal of dermatology.

Summary of the current status of clinically diagnosed cases of Schnitzler syndrome in Japan.

T. Nomura, K. Migita, T. Nagano, 2022, Allergology international : official journal of the Japanese Society of Allergology.

Inducible skin‐associated lymphoid tissue (iSALT) in a patient with Schnitzler syndrome who manifested wheals on recurrent localized erythema

T. Nomura, K. Kabashima, A. Otsuka, 2021, The British journal of dermatology.

Interleukin-13 inhibition by tralokinumab reduces inducible T-cell costimulator-positive innate lymphoid cells in skin lesions of atopic dermatitis.

T. Nomura, K. Kabashima, N. Kambe, 2022, The British journal of dermatology.